Aghion P, Howitt I. Endogenous Growth. Cambridge Ma: MIT Press, 1998.Audretsch D. Agglomeration and the location of Innovative Activity. Oxford Review of Economic Policy 1989;14(2).Biotechnology Clusters, (1999) Informe del grupo de trabajo liderado por Lord Sainsbury, Ministro de Ciencia del Reino Unido.Commission of the European Communities. Communication from the Commission. Investing in Research: an action plan for Europe.Brussels: COM, 2003; p. 22226.Commission of the European Communities. Life Sciences and Biotechnology. A Strategy for Europe. Brussels: COM, 2002; p. 27.Commission of the European Communities. Science and Technology, the Key to Europe's Future. Guidelines for future European Union Policy to support research. Brussels: COM, 2004; p. 353Cooke P, Morgan KK. The Associational Economy: Firms, Regions and Innovation. Oxford University Press, 1998.COTEC, 2004. Transferencia a las empresas de la investigación universitaria. Descripción de modelos europeos.
Crowly WF, Sherwood L, et al. Clinical Research in the United States at Crossroads. Proposal for a novel publicprivate partnership to establish a National Clinical enterprise. JAMA 2004;291(9).DTI. BIOSCIENCE 2015. Report by the Bioscience innovation and Grown Team.WIPO and IASP. Joint Seminal for Science Parks and Business Incubators. Geneva.02.07.2004.Ernst, Young, 2003. Pharma projects for US; European Company DataNalebuff BJ, Brandenburguer AM. Co-petition. London: Harper – Collins Business, 1996.Organization for Cooperation and Economic Development (OCDE), 2006.The policy mix for research,development and innovation in Spain-key Issues and policy recommendations.Porter M. The Competitive Advantage of Nations.Prezever D., 1997 The dynamics of Industrial Clustering in Biotechnology. Small Bussiness EconomicsRubiralta, M; Vendrell M.; Viladiu, C., 2005. Las Biorregiones. Un instrumento para mejorar la competitividad.Sykes RB. New Medicines, the Practice of Medicine and Public Policy. The Rock Carling Fellowship The Nuffield Trust. 2000.
